• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用头孢曲松单剂量疗法治疗新生儿淋菌性眼炎。

Single-dose therapy of gonococcal ophthalmia neonatorum with ceftriaxone.

作者信息

Laga M, Naamara W, Brunham R C, D'Costa L J, Nsanze H, Piot P, Kunimoto D, Ndinya-Achola J O, Slaney L, Ronald A R

出版信息

N Engl J Med. 1986 Nov 27;315(22):1382-5. doi: 10.1056/NEJM198611273152203.

DOI:10.1056/NEJM198611273152203
PMID:3095641
Abstract

We conducted a randomized clinical trial comparing a single intramuscular dose of 125 mg of ceftriaxone with a single intramuscular dose of 75 mg of kanamycin followed by topical gentamicin for seven days, and with a single intramuscular dose of 75 mg of kanamycin followed by topical tetracycline for seven days, in the treatment of gonococcal ophthalmia neonatorum in Nairobi, Kenya. Of 122 newborns with culture-proved gonococcal ophthalmia neonatorum, 105 returned for follow-up. Sixty-one infants (54 percent) received ceftriaxone, 32 received kanamycin plus topical gentamicin, and 29 received kanamycin plus topical tetracycline. Sixty-six (54 percent) of the Neisseria gonorrhoeae isolates were penicillinase producing. All 55 newborns who received ceftriaxone and returned for follow-up were clinically and microbiologically cured. One of 26 returning newborns who received kanamycin plus tetracycline and 2 of 24 returning newborns who received kanamycin plus gentamicin had persistent or recurrent gonococcal conjunctivitis. Ceftriaxone also eradicated oropharyngeal gonococcal infection in 18 newborns, whereas oropharyngeal infection persisted in 2 of 8 newborns who had received kanamycin (P not significant). We conclude that 125 mg of ceftriaxone as a single intramuscular dose is very effective therapy for gonococcal ophthalmia neonatorum, with marked efficacy against extraocular infection and without the need for concomitant topical antimicrobial therapy.

摘要

我们在肯尼亚内罗毕进行了一项随机临床试验,比较单次肌内注射125mg头孢曲松、单次肌内注射75mg卡那霉素后外用庆大霉素7天以及单次肌内注射75mg卡那霉素后外用四环素7天,用于治疗新生儿淋菌性眼炎。在122例经培养证实为新生儿淋菌性眼炎的新生儿中,105例返回接受随访。61例婴儿(54%)接受了头孢曲松治疗,32例接受了卡那霉素加外用庆大霉素治疗,29例接受了卡那霉素加外用四环素治疗。66株(54%)淋病奈瑟菌分离株产青霉素酶。所有55例接受头孢曲松治疗并返回接受随访的新生儿在临床和微生物学上均治愈。接受卡那霉素加四环素治疗的26例返回新生儿中有1例、接受卡那霉素加庆大霉素治疗的24例返回新生儿中有2例患有持续性或复发性淋菌性结膜炎。头孢曲松还根除了18例新生儿的口咽淋菌感染,而接受卡那霉素治疗的8例新生儿中有2例口咽感染持续存在(P值无统计学意义)。我们得出结论,单次肌内注射125mg头孢曲松是治疗新生儿淋菌性眼炎的非常有效的疗法,对眼外感染有显著疗效,且无需同时进行外用抗菌治疗。

相似文献

1
Single-dose therapy of gonococcal ophthalmia neonatorum with ceftriaxone.用头孢曲松单剂量疗法治疗新生儿淋菌性眼炎。
N Engl J Med. 1986 Nov 27;315(22):1382-5. doi: 10.1056/NEJM198611273152203.
2
Single-dose kanamycin therapy of gonococcal ophthalmia neonatorum.新生儿淋菌性眼炎的单剂量卡那霉素治疗
Lancet. 1984 Dec 1;2(8414):1234-7. doi: 10.1016/s0140-6736(84)92794-6.
3
Single-dose ceftriaxone therapy of gonococcal ophthalmia neonatorum.新生儿淋菌性眼炎的单剂量头孢曲松治疗。
Sex Transm Dis. 1986 Jan-Mar;13(1):53-5. doi: 10.1097/00007435-198601000-00012.
4
Prophylaxis of gonococcal and chlamydial ophthalmia neonatorum. A comparison of silver nitrate and tetracycline.新生儿淋菌性和衣原体性眼炎的预防。硝酸银与四环素的比较。
N Engl J Med. 1988 Mar 17;318(11):653-7. doi: 10.1056/NEJM198803173181101.
5
Management of gonococcal ophthalmia neonatorum with single-dose kanamycin and ocular irrigation with saline.单剂量卡那霉素治疗新生儿淋菌性眼炎及生理盐水眼部冲洗
Sex Transm Dis. 1988 Apr-Jun;15(2):108-9. doi: 10.1097/00007435-198804000-00008.
6
Ophthalmia neonatorum--the Middle Road Hospital perspective.新生儿眼炎——中路医院视角
Ann Acad Med Singap. 1987 Oct;16(4):645-7.
7
New issues in the prevention and treatment of ophthalmia neonatorum.新生儿眼炎防治的新问题
Ann Ophthalmol. 1983 Nov;15(11):1004, 1006-9.
8
Single-dose cefotaxime intramuscularly cures gonococcal ophthalmia neonatorum.单剂量头孢噻肟肌内注射可治愈新生儿淋菌性眼炎。
Br J Ophthalmol. 1988 Jul;72(7):518-20. doi: 10.1136/bjo.72.7.518.
9
Epidemiology and control of gonococcal ophthalmia neonatorum.新生儿淋菌性眼炎的流行病学与防治
Bull World Health Organ. 1989;67(5):471-7.
10
Penicillinase-producing Neisseria gonorrhoeae ophthalmia neonatorum in Singapore.新加坡产青霉素酶的淋病奈瑟菌所致新生儿眼炎
Br J Vener Dis. 1982 Oct;58(5):308-10. doi: 10.1136/sti.58.5.308.

引用本文的文献

1
Antibiotic prophylaxis for ophthalmia neonatorum in Italy: results from a national survey and the Italian intersociety new position statements.意大利新生儿眼炎的抗生素预防:全国调查和意大利多个学会新立场声明的结果。
Ital J Pediatr. 2023 Sep 11;49(1):117. doi: 10.1186/s13052-023-01507-7.
2
Interventions for preventing ophthalmia neonatorum.预防新生儿眼炎的干预措施。
Cochrane Database Syst Rev. 2020 Sep 21;9(9):CD001862. doi: 10.1002/14651858.CD001862.pub4.
3
The Treatment of Possible Severe Infection in Infants: An Open Randomized Safety Trial of Parenteral Benzylpenicillin and Gentamicin Versus Ceftriaxone in Infants <60 days of Age in Malawi.
婴儿可能的严重感染的治疗:在马拉维对60日龄以下婴儿进行的一项关于肠外注射苄青霉素和庆大霉素与头孢曲松对比的开放性随机安全性试验。
Pediatr Infect Dis J. 2017 Dec;36(12):e328-e333. doi: 10.1097/INF.0000000000001576.
4
Bacterial conjunctivitis.细菌性结膜炎
BMJ Clin Evid. 2012 Feb 20;2012:0704.
5
Bacterial conjunctivitis.细菌性结膜炎
BMJ Clin Evid. 2010 Mar 15;2010:0704.
6
Antibiotic treatment of gonorrhoea--clinical evidence for choice.淋病的抗生素治疗——选择的临床证据
Genitourin Med. 1996 Oct;72(5):315-20. doi: 10.1136/sti.72.5.315.
7
STD in children: syphilis and gonorrhoea.儿童性传播疾病:梅毒和淋病。
Genitourin Med. 1993 Feb;69(1):66-75. doi: 10.1136/sti.69.1.66.
8
Ceftriaxone. A reappraisal of its antibacterial activity and pharmacokinetic properties, and an update on its therapeutic use with particular reference to once-daily administration.头孢曲松。对其抗菌活性和药代动力学特性的重新评估,以及关于其治疗用途的最新情况,特别提及每日一次给药。
Drugs. 1988 Jun;35(6):604-45. doi: 10.2165/00003495-198835060-00002.
9
Neonatal septicemia.新生儿败血症
Indian J Pediatr. 1988 Mar-Apr;55(2):225-33. doi: 10.1007/BF02722186.
10
Clinical pharmacokinetics of ceftriaxone.头孢曲松的临床药代动力学。
Clin Pharmacokinet. 1989 Oct;17(4):223-35. doi: 10.2165/00003088-198917040-00002.